A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization

Among different types of EGFR dimers, EGFR-HER2 and HER2-HER3 are well known in different types of cancers. Targeting dimerization of EGFR will have a significant impact on cancer therapies. A symmetric peptidomimetic was designed to inhibit the protein-protein interaction of EGFR. The peptidomimeti...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Kanthala, Shanthi P., Liu, Yong-Yu, Singh, Sitanshu, Sable, Rushikesh, Pallerla, Sandeep, Jois, Seetharama D.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2017
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5650337/
https://ncbi.nlm.nih.gov/pubmed/29088782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19013
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg